Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Breast Cancer Research and Treatment|May 7, 2013
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancerN U Lin, D S Seah, R Gelman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2020
Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancerS Adams, V Diéras, C H Barrios, et al.Oncogene|December 8, 2015
PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signalingH Cheng, P Liu, C Ohlson, et al.Breast Cancer Research and Treatment|June 11, 2008
The impact of sharing results of a randomized breast cancer clinical trial with study participantsAnn H Partridge, A C Wolff, P K Marcom, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Attitudes of patients with metastatic breast cancer toward research biopsiesD S Seah, S M Scott, J Najita, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastasesO Metzger Filho, J P Leone, T Li, et al.ESMO Open|February 11, 2026
Circulating tumor DNA in neoadjuvant endocrine therapy for early breast cancerA Grinshpun, D Dustin, M Cai, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2019
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinomaE L Mayer, A DeMichele, H S Rugo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2021
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysisL A Emens, S Adams, C H Barrios, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase II evaluation of thalidomide in patients with metastatic breast cancerS M Baidas, E P Winer, G F Fleming, et al.Pageof 9